Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
25 Total results for product and free and sample content found
Datamonitor Healthcare
By Ljlal Syed, Mark Lansdell and David Abramson 19 Aug 2017
This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic
Topic Deal trends
RxScorecard
17 Aug 2017
See how the value of drugs differentiate therapies by sub-population. Find out where the disproportionate value of your drug lies alongside competitors. Uncover demonstrable differentiated value when entering a crowded market. Discover the power of RxScorecard™.
Topic Reimbursement
Datamonitor Healthcare
By Colin White, Robert Jeng & Jolene Lau 17 Aug 2017
This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well
Topic immuno-oncology
Datamonitor Healthcare
05 Aug 2017
Big Pharma Outlook 2026 takes decade-long look at what’s in store for the future of Big Pharma.
Biomedtracker
17 Jul 2017
In this report, we cover catalysts from 21 drugs expected to occur in Q3 2017. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.
Topic Alzheimers Cancer Drug approval
Strategic Transactions, Scrip
22 May 2017
Featured recently in The Telegraph and The Times, Building something great: UK’s Global Bioscience Cluster 2016, the pivotal report from Informa Pharma Intelligence and The UK BioIndustry Association, is now available to you in its entirety as a free download.
Pharmaprojects
By Ian Lloyd 13 Apr 2017
Following on from our review of trends in the current pharmaceutical R&D pipeline, published in March 2017, this supplement takes a look at the industry’s success stories of 2016 – the drugs which were launched on to the market for the first time during the year.
Biomedtracker
23 Mar 2017
There is no doubt that 2016 will be marked as year of surprising results. None more so than how life science companies fared in the capital markets.
Topic Business strategies
Pharmaprojects
27 Feb 2017
Over 350 million people worldwide are suffering from rare diseases. Which is why it is necessary to understand the rare disease landscape to date.
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
